Terminalia albida
Terminalia albida · Accepted scientific name
Scientific literature: Very Sparse (10 studies) · ★☆☆☆☆
Terminalia albida is a versatile plant species that has garnered significant scientific interest due to its diverse pharmacological properties. Research indicates that various preparations, including root bark and n-BuOH extracts, possess potent antimicrobial and antioxidant activities. Specifically, these plant extracts have demonstrated strong antiplasmodial and antimalarial potential against the pathogen Plasmodium falciparum. Furthermore, the plant shows promise in combating fungal infections caused by Candida albicans and managing various forms of inflammation. By utilizing the root and stem, researchers aim to harness these bioactive compounds for therapeutic applications.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Root · Stem
Classification
Taxonomy
Terminalia albida is a distinctive botanical species that belongs to the vast kingdom Plantae. Within this expansive kingdom, it is specifically classified under the class Equisetopsida. Its taxonomic journey continues through the order Myrtales, which helps define its evolutionary lineage. Furthermore, this plant is a member of the Combretaceae family, showcasing its unique biological characteristics. Ultimately, it is identified by its specific genus, Terminalia, marking its place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia albida is a widespread species primarily concentrated throughout the West Tropical Africa region. Its natural distribution spans several key nations, including Burkina Faso and the Gambia. The plant also thrives within the diverse landscapes of Guinea and Guinea-Bissau. Furthermore, its presence extends into the lush environments of the Ivory Coast. This broad geographic range highlights the plant's ecological significance across the West African belt.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia albida grows in a shrub form and is characterized by its self-supporting structure. This species reaches a maximum height of approximately 12.19 meters. Its sturdy development makes it a notable feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia albida is a medicinal plant widely utilized in Guinean traditional medicine for its diverse therapeutic properties. Research has confirmed its significant antimicrobial activity, specifically showing effectiveness against pathogens such as Candida albicans. The plant also demonstrates potent antiplasmodial and antimalarial effects, which have been validated through both in vitro studies and in vivo murine models. Furthermore, its ability to scavenge reactive oxygen species highlights a remarkable antioxidant capacity that contributes to its medicinal value. These combined biological activities suggest that the species is a promising source for developing new therapeutic agents to combat infectious diseases.
Compounds
Terminalia albida is a plant species widely utilized in Guinean traditional medicine that contains a variety of bioactive compounds. Research involving the bioassay-guided fractionation of its roots has successfully identified several key constituents, including the phenol glycoside calophymembranside B. The plant also contains important triterpenes such as arjunic acid and arjunolic acid. Furthermore, the chemical profile of the species includes the presence of arjunglucoside II. Among the isolated substances, pantolactone stands out for demonstrating significant activity against Plasmodium falciparum.
Conditions
Terminalia albida demonstrates significant medicinal potential through its ability to treat Plasmodium falciparum, effectively acting as an antimalarial agent. Research confirms that this plant species treats malaria by exhibiting potent in vitro and in vivo antiplasmodial activities. Furthermore, methanolic extracts of its stem bark have shown promising results in the treatment of Candida albicans. The plant also possesses specialized antimicrobial properties that allow it to treat Mycobacterium chelonae. These diverse capabilities validate its traditional use in managing various parasitic and fungal infections.
Preparations
Terminalia albida is prepared as root bark to facilitate the isolation of various oleanane triterpenoids. This species is also prepared as an n-BuOH extract for detailed phytochemical investigations. Researchers utilize Terminalia albida prepared as a plant extract to evaluate its anti-malarial, anti-inflammatory, and antioxidant properties. Furthermore, the plant is prepared as stem bark, which has yielded several putatively identified compounds such as tannins and triterpenoids. These different forms of Terminalia albida extracts are essential for studying the plant's potential in treating diseases like malaria.
Parts used
Terminalia albida is a significant medicinal plant utilized extensively in Guinean traditional medicine to treat various infectious diseases. Scientific investigations have highlighted the therapeutic potential of its different parts, specifically the stem and the root. Extracts derived from the stem bark have demonstrated promising antimicrobial activity against pathogens such as Candida albicans. Furthermore, the root and its bark have shown potent antiplasmodial properties, making them valuable for combating Plasmodium falciparum. These findings underscore the importance of utilizing both the stem and root components of the species for the development of new antimalarial and antifungal agents.